Stock Watch: The Rise Of Vaccine Cannibalism
Sales Of Non-Coronavirus Vaccines Are Not Immune To The Pandemic
Executive Summary
Influenza and pneumococcal vaccine sales were initially strong at the start of the pandemic. Recent weak revenues for travel, childhood and premium vaccines could raise population immunity concerns, however.
You may also be interested in...
CDC Advisors Like Pfizer’s COVID Vaccine For Adolescents But Are Less Sure Of Coadministration
Without giving ACIP a chance to vote on the change or providing additional data, CDC announces new guidance allowing coadministration of COVID-19 vaccines with other immunizations. Needless to say, the decision raised a few eyebrows.
Merck & Co.'s Transitional Year Is Off To A Sluggish Start
The company, in the midst of a leadership and structural transition, said the pandemic negatively impacted revenues by about $600m.
GSK Sees Light At End Of Shingrix Tunnel As COVID-19 Eases
A CDC recommendation slowed non-pandemic vaccinations, but Shingrix shots will likely increase as more eligible consumers are fully vaccinated against SARS-CoV-2.